Literature DB >> 2833407

Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine.

G Giammanco1, V De Grandi, L Lupo, A Mistretta, S Pignato, D Teuween, H Bogaerts, F E Andre.   

Abstract

A vaccination trial, performed on 86 3-month-old infants, has shown that the ability of the RIT 4237 live attenuated rotavirus strain to induce seroconversion is dramatically reduced when administered with live poliovirus vaccine. In a subsequent trial performed on 93 infants the attempt to overcome the poliovirus interference by administering two doses of associated vaccines was unsuccessful. No interference by the RIT 4237 strain on live attenuated polioviruses was observed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2833407     DOI： 10.1007/BF00152704

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  5 in total

1.  Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain.

Authors:  I Vodopija; Z Baklaic; R Vlatkovic; H Bogaerts; A Delem; F E Andre
Journal:  Vaccine       Date:  1986-12       Impact factor: 3.641

2.  The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data.

Authors:  J D Snyder; M H Merson
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

3.  Detection of serum antibody responses to RIT 4237 rotavirus vaccine by ELISA and neutralization assays.

Authors:  A Delem; T Vesikari
Journal:  J Med Virol       Date:  1987-03       Impact factor: 2.327

4.  Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.

Authors:  T Vesikari; E Isolauri; E D'Hondt; A Delem; F E André; G Zissis
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

5.  Pediatric viral gastroenteritis during eight years of study.

Authors:  C D Brandt; H W Kim; W J Rodriguez; J O Arrobio; B C Jeffries; E P Stallings; C Lewis; A J Miles; R M Chanock; A Z Kapikian; R H Parrott
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948
  5 in total
  6 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Preeradication vaccine policy options for poliovirus infection and disease control.

Authors:  Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Jong-Hoon Kim; Stephen L Cochi
Journal:  Risk Anal       Date:  2013-03-05       Impact factor: 4.000

3.  Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis.

Authors:  Constantina Boikos; Jesse Papenburg; Christine Martineau; Lawrence Joseph; David Scheifele; Mark Chilvers; Larry C Lands; Gaston De Serres; Caroline Quach
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

Review 4.  Rotavirus vaccines: an overview.

Authors:  K Midthun; A Z Kapikian
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  Interventions to improve oral vaccine performance: a systematic review and meta-analysis.

Authors:  James A Church; Edward P Parker; Beth D Kirkpatrick; Nicholas C Grassly; Andrew J Prendergast
Journal:  Lancet Infect Dis       Date:  2019-01-30       Impact factor: 71.421

6.  Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants.

Authors:  James A Church; Bernard Chasekwa; Sandra Rukobo; Margaret Govha; Benjamin Lee; Marya P Carmolli; Robert Ntozini; Kuda Mutasa; Monica M McNeal; Florence D Majo; Naume V Tavengwa; Beth D Kirkpatrick; Lawrence H Moulton; Jean H Humphrey; Andrew J Prendergast
Journal:  Vaccine       Date:  2020-02-19       Impact factor: 3.641
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.